Know Labs Inc (KNW)

[tim00mike]

This Company Reports Moving Toward FDA Approval To Provide Pain-Free Diabetes Monitoring

https://www.benzinga.com/general/biotech/22/08/28431449/this-company-reports-moving-toward-fda-approval-to-provide-pain-free-diabetes-monitoring

Know Labs Inc.
KNWN
, an emerging developer in noninvasive medical diagnostics, focuses on developing its proprietary spectroscopic technologies using the electromagnetic spectrum. The goal is to accurately identify and measure a wide range of organic and inorganic materials, molecules and compositions of matter.

Know Labs’ technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. It refers to its technology as Bio-RFID™, which can be integrated into various wearable, mobile or bench-top devices. The company’s patented and patent-pending technology makes it possible to effectively identify and monitor analyses that could only previously be performed by invasive, expensive and time-consuming lab-based tests.

The first application of its Bio-RFID technology will reportedly be in a product marketed as a noninvasive glucose monitor, giving the user real-time information on blood glucose levels.

Know Labs’ leadership says it's confident it will be the first company to bring an FDA-cleared noninvasive glucose monitoring device to market. Know Labs is conducting a 200-person internal clinical trial of Bio-RFID, which will help the company refine its algorithm and demonstrate Bio-RFID’s accuracy in a large population... Previous internal tests demonstrated Bio-RFID has accuracy on par or better than currently available solutions, which is an important step toward FDA submission.

For more information on Know Labs Inc., visit knowlabs.co.